Man Group
TDOC icon

Man Group’s Teladoc Health TDOC Stock Holding History

Man Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$36K – 2399
2022
Q1 		$36K Sell
500
-2,800
-85% -$202K ﹤0.01% 2136
2021
Q4 		$303K Buy
+3,300
New +$394K ﹤0.01% 1678

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's TDOC Position: Q1 2026 in Review

Man Group increased its Teladoc Health (TDOC) stake by 86% in Q1 2026, buying an estimated $7.86M and bringing the position to 3,021,550 shares worth $16.5M. The position accounts for 0.03% of the portfolio, ranked #588.

Man Group first reported a position in TDOC in Q2 2018 and has held it in 27 quarters since. The position peaked at $42.8M in Q4 2023. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Man Group held 3,021,550 shares of Teladoc Health worth $16.5M as of Q1 2026.
  • Man Group bought 1,400,917 Teladoc Health shares in Q1 2026, an estimated $7.86M.
  • Teladoc Health made up 0.03% of Man Group's portfolio in Q1 2026, its #588 holding.
  • Man Group first reported a position in Teladoc Health in Q2 2018 and has held it in 27 quarters since.
  • Man Group's Teladoc Health position peaked at $42.8M in Q4 2023.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.